XML 35 R19.htm IDEA: XBRL DOCUMENT
v3.26.1

Fair Value Measurements | 6 Months Ended
--- | ---
Jun. 30, 2026
Fair Value Disclosures [Abstract] |
Fair Value Measurements | Note 11 – Fair Value Measurements The fair value of an asset or liability is the price that would be received to sell that asset or paid to transfer that liability in an orderly transaction occurring in the principal market (or most advantageous market in the absence of a principal market) for such asset or liability. In estimating fair value, the Company utilizes valuation techniques that are consistent with the market approach, the income approach and/or the cost approach. Such valuation techniques are consistently applied. Inputs to valuation techniques include the assumptions that market participants would use in pricing an asset or liability. ASC 820, "Fair Value Measurements and Disclosures", establishes a fair value hierarchy for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The fair value hierarchy is as follows: Level 1 Quoted prices in active exchange markets for identical assets or liabilities. Level 2 Observable inputs other than Level 1 including quoted prices for similar assets or liabilities, quoted prices in less active markets or other observable inputs that can be corroborated by observable market data; also includes derivative contracts whose value is determined using a pricing model with observable market inputs or inputs that can be derived principally from or corroborated by observable market data. This category generally includes certain U.S. Government and agency securities, corporate debt securities, and derivative instruments. Level 3 Unobservable inputs supported by little or no market activity for financial instruments whose value is determined using pricing models, discounted cash flow methodologies or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation; also includes observable inputs for single dealer nonbinding quotes not corroborated by observable market data. This category generally includes certain private equity investments, retained interests from securitizations and certain collateralized debt obligations. Assets and Liabilities Recorded at Fair Value on a Recurring Basis The table below presents the recorded amount of assets and liabilities measured at fair value on a recurring basis.
|  | As of June 30, 2026
(dollars in thousands) |  | Quoted Prices (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Other Unobservable Inputs (Level 3) |  | Total Fair Value
Assets: |  |  |  |  |  |  |  |
Investment securities available-for-sale: |  |  |  |  |  |  |  |
U.S. agency securities |  | $ | — |  |  | $ | 313,772 |  |  | $ | — |  |  | $ | 313,772 |
Residential mortgage-backed securities |  | — |  |  | 514,748 |  |  | — |  |  | 514,748 |
Commercial mortgage-backed securities |  | — |  |  | 65,734 |  |  | — |  |  | 65,734 |
Municipal bonds |  | — |  |  | 7,943 |  |  | — |  |  | 7,943 |
Corporate bonds |  | — |  |  | 1,986 |  |  | — |  |  | 1,986 |
Derivative assets |  | — |  |  | 25,254 |  |  | — |  |  | 25,254 |
Total assets measured at fair value on a recurring basis |  | $ | — |  |  | $ | 929,437 |  |  | $ | — |  |  | $ | 929,437 |
Liabilities: |  |  |  |  |  |  |  |
Derivative liabilities |  | $ | — |  |  | $ | 37,964 |  |  | $ | — |  |  | $ | 37,964 |
Total liabilities measured at fair value on a recurring basis |  | $ | — |  |  | $ | 37,964 |  |  | $ | — |  |  | $ | 37,964 |
|  | As of December 31, 2025
(dollars in thousands) |  | Quoted Prices (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Other Unobservable Inputs (Level 3) |  | Total Fair Value
Assets: |  |  |  |  |  |  |  |
Investment securities available-for-sale: |  |  |  |  |  |  |  |
U.S. agency securities |  | — |  |  | 337,708 |  |  | — |  |  | 337,708 |
Residential mortgage-backed securities |  | — |  |  | 562,504 |  |  | — |  |  | 562,504 |
Commercial mortgage-backed securities |  | — |  |  | 66,545 |  |  | — |  |  | 66,545 |
Municipal bonds |  | — |  |  | 8,046 |  |  | — |  |  | 8,046 |
Corporate bonds |  | — |  |  | 1,967 |  |  | — |  |  | 1,967 |
Derivative assets |  | — |  |  | 24,332 |  |  | — |  |  | 24,332 |
Total assets measured at fair value on a recurring basis |  | $ | — |  |  | $ | 1,001,102 |  |  | $ | — |  |  | $ | 1,001,102 |
Liabilities: |  |  |  |  |  |  |  |
Derivative liabilities |  | $ | — |  |  | $ | 23,942 |  |  | $ | — |  |  | $ | 23,942 |
Total liabilities measured at fair value on a recurring basis |  | $ | — |  |  | $ | 23,942 |  |  | $ | — |  |  | $ | 23,942 |
Investment securities available-for-sale: AFS securities are recorded at fair value on a recurring basis. Fair value measurement is based upon quoted prices, if available. If quoted prices are not available, fair value is measured using independent pricing models or other model-based valuation techniques such as the present value of future cash flows, adjusted for the security’s credit rating, prepayment assumptions and other factors such as credit loss assumptions. Level 2 securities includes certain U.S. treasury bonds, U.S. agency debt securities, MBS issued by Government Sponsored Entities and municipal bonds. Securities classified as Level 3 include securities in less liquid markets, for which the carrying amounts approximate the fair value. Interest rate derivatives: The Company entered into an interest rate derivative agreement with an institutional counterparty, under which the Company will receive cash if and when market rates exceed the derivatives' strike rate. The fair value of the derivative is calculated by determining the total expected asset or liability exposure of the derivatives. Total expected exposure incorporates both the current and potential future exposure of the derivative, derived from using observable inputs, such as yield curves and volatilities. Accordingly, the derivative falls within Level 2. Assets and Liabilities Recorded at Fair Value on a Nonrecurring Basis The Company measures certain assets at fair value on a nonrecurring basis and the following is a general description of the methods used to value such assets. Loans: The fair value of individually assessed loans and HFS loans is estimated using one of several methods, including the collateral value, market value of similar debt, enterprise value, liquidation value and discounted cash flows. Those individually assessed loans not requiring a specific allowance represent loans for which the fair value of expected repayments or collateral exceed the recorded investment in such loans. As of June 30, 2026, substantially all of the Company’s individually evaluated loans were evaluated based upon the fair value of the collateral. In accordance with ASC Topic 820, individually evaluated loans and HFS loans where an allowance is established based on the fair value of collateral, i.e., those that are collateral dependent, require classification in the fair value hierarchy. When the fair value of the collateral is based on an observable market price, the Company records the loan as nonrecurring Level 2. When management determines the fair value of the collateral based on the appraised value and there is no observable market price, the Company records the loan as nonrecurring Level 3. Other real estate owned ("OREO"): OREO is initially recorded at fair value less estimated selling costs. Fair value is based upon independent market prices, appraised values of the collateral or management’s estimation of the value of the collateral, which the Company classifies as a Level 3 valuation. The table below presents assets measured at fair value on a nonrecurring basis. There were no liabilities measured at fair value on a non-recurring basis as of June 30, 2026 and December 31, 2025.
|  | As of June 30, 2026
(dollars in thousands) |  | Quoted Prices (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Other Unobservable Inputs (Level 3) |  | Total Fair Value
Individually assessed loans: |  |  |  |  |  |  |  |
Commercial |  | $ | — |  |  | $ | — |  |  | $ | 15,890 |  |  | $ | 15,890 |
Income producing - commercial real estate |  | — |  |  | — |  |  | 66,021 |  |  | 66,021 |
Owner occupied - commercial real estate |  | — |  |  | — |  |  | 5,095 |  |  | 5,095 |
Real estate mortgage - residential |  | — |  |  | — |  |  | 552 |  |  | 552 |
Construction - commercial and residential |  | — |  |  | — |  |  | 4,883 |  |  | 4,883 |
Consumer |  | — |  |  | — |  |  | 492 |  |  | 492 |
Loans held for sale |  | — |  |  | — |  |  | 49,663 |  |  | 49,663 |
Other real estate owned |  | — |  |  | — |  |  | 1,966 |  |  | 1,966 |
Total assets measured at fair value on a nonrecurring basis |  | $ | — |  |  | $ | — |  |  | $ | 144,562 |  |  | $ | 144,562 |
|  | As of December 31, 2025
(dollars in thousands) |  | Quoted Prices (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Other Unobservable Inputs (Level 3) |  | Total Fair Value
Individually assessed loans: |  |  |  |  |  |  |  |
Commercial |  | $ | — |  |  | $ | — |  |  | $ | 8,580 |  |  | $ | 8,580 |
Income producing - commercial real estate |  | — |  |  | — |  |  | 59,655 |  |  | 59,655 |
Owner occupied - commercial real estate |  | — |  |  | — |  |  | 3,695 |  |  | 3,695 |
Real estate mortgage - residential |  | — |  |  | — |  |  | 579 |  |  | 579 |
Construction - commercial and residential |  | — |  |  | — |  |  | 14,460 |  |  | 14,460 |
Consumer |  | — |  |  | — |  |  | 333 |  |  | 333 |
Loans held for sale |  | — |  |  | — |  |  | 90,650 |  |  | 90,650 |
Other real estate owned |  | — |  |  | — |  |  | 2,059 |  |  | 2,059 |
Total assets measured at fair value on a nonrecurring basis |  | $ | — |  |  | $ | — |  |  | $ | 180,011 |  |  | $ | 180,011 |
As shown in the table above, certain assets are measured at fair value on a nonrecurring basis in accordance with GAAP. Adjustments to the fair value of these assets usually result from the application of lower-of-cost-or-fair value accounting or write-downs of individual assets after they are evaluated for impairment. The primary assets accounted for at fair value on a nonrecurring basis are related to collateral-dependent loans that are individually assessed and other real estate owned. For the collateral-dependent loans and other real estate owned, the Company measures the fair value utilizing a market valuation approach, based on an appraisal conducted by an independent, licensed appraiser. Management may discount the value from the appraisal in determining the fair value if, based on its understanding of the market conditions, the collateral had been impaired below the appraised value (Level 3). For loans that are not collateral dependent, the Company uses an income approach, specifically, the discounted cash flow method. The continuing payments are discounted over the expected life at the loan’s original contract rate and include adjustments for risk of default. Fair Value of Financial Instruments The Company discloses fair value information about financial instruments for which it is practicable to estimate the value, whether or not such financial instruments are recognized on the balance sheet. Fair value is the amount at which a financial instrument could be exchanged in a current transaction between willing parties, other than in a forced sale or liquidation, and is best evidenced by quoted market price, if one exists. Quoted market prices, if available, are shown as estimates of fair value. Because no quoted market prices exist for a portion of the Company’s financial instruments, the fair value of such instruments has been derived based on management’s assumptions with respect to future economic conditions, the amount and timing of future cash flows and estimated discount rates. Different assumptions could significantly affect these estimates. Accordingly, the net realizable value could be materially different from the estimates presented below. In addition, the estimates are only indicative of individual financial instrument values, including in certain cases, the Company's estimation of exit pricing, and should not be considered an indication of the fair value of the Company taken as a whole. The table below presents the estimated fair values of the Company’s financial instruments.
|  |  |  |  |  | Fair Value Measurements
(dollars in thousands) |  | Carrying Value |  | Fair Value |  | Quoted Prices (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Other Unobservable Inputs (Level 3)
As of June 30, 2026 |  |  |  |  |  |  |  |  |  |
Assets |  |  |  |  |  |  |  |  |  |
Cash and due from banks |  | $ | 13,394 |  |  | $ | 13,394 |  |  | $ | 13,394 |  |  | $ | — |  |  | $ | — |
Interest-bearing deposits with other banks |  | 612,349 |  |  | 612,349 |  |  | — |  |  | 612,349 |  |  | — |
Investment securities available-for-sale |  | 904,183 |  |  | 904,183 |  |  | — |  |  | 904,183 |  |  | — |
Investment securities held-to-maturity |  | 814,878 |  |  | 730,994 |  |  | — |  |  | 730,994 |  |  | — |
Federal Reserve and Federal Home Loan Bank stock |  | 32,500 |  |  | N/A |  | — |  |  | — |  |  | — |
Loans held for sale |  | 49,663 |  |  | 49,663 |  |  | — |  |  |  |  | 49,663 |
Loans held for investment |  | 6,622,435 |  |  | 6,505,181 |  |  | — |  |  | — |  |  | 6,505,181 |
Bank-owned life insurance |  | 345,469 |  |  | 345,469 |  |  | — |  |  | 345,469 |  |  | — |
Annuity investment |  | 11,558 |  |  | 11,558 |  |  | — |  |  | 11,558 |  |  | — |
Interest rate product |  | 25,254 |  |  | 25,254 |  |  | — |  |  | 25,254 |  |  | — |
Accrued interest receivable |  | 36,050 |  |  | 36,050 |  |  | — |  |  | 36,050 |  |  | — |
Liabilities |  |  |  |  |  |  |  |  |  |
Noninterest-bearing deposits |  | 1,567,336 |  |  | 1,567,336 |  |  | — |  |  | 1,567,336 |  |  | — |
Interest-bearing deposits |  | 4,035,638 |  |  | 4,035,638 |  |  | — |  |  | 4,035,638 |  |  | — |
Time deposits |  | 2,582,123 |  |  | 2,582,686 |  |  | — |  |  | 2,582,686 |  |  | — |
Other short-term borrowings |  | 100,000 |  |  | 100,000 |  |  | — |  |  | 100,000 |  |  | — |
Long-term borrowings |  | 76,593 |  |  | 79,397 |  |  | — |  |  | 79,397 |  |  | — |
Interest rate product |  | 37,964 |  |  | 37,964 |  |  | — |  |  | 37,964 |  |  | — |
Accrued interest payable |  | 9,598 |  |  | 9,598 |  |  | — |  |  | 9,598 |  |  | — |
As of December 31, 2025 |  |  |  |  |  |  |  |  |  |
Assets |  |  |  |  |  |  |  |  |  |
Cash and due from banks |  | $ | 11,692 |  |  | $ | 11,692 |  |  | $ | 11,692 |  |  | $ | — |  |  | $ | — |
Interest-bearing deposits with other banks |  | 684,001 |  |  | 684,001 |  |  | — |  |  | 684,001 |  |  | — |
Investment securities available-for-sale |  | 976,770 |  |  | 976,770 |  |  | — |  |  | 976,770 |  |  | — |
Investment securities held-to-maturity |  | 854,780 |  |  | 774,947 |  |  | — |  |  | 774,947 |  |  | — |
Federal Reserve and Federal Home Loan Bank stock |  | 28,327 |  |  | N/A |  | — |  |  | — |  |  | — |
Loans held for sale |  | 90,650 |  |  | 90,650 |  |  | — |  |  |  |  | 90,650 |
Loans held for investment |  | 7,280,459 |  |  | 7,093,276 |  |  | — |  |  | — |  |  | 7,093,276 |
Bank-owned life insurance |  | 335,177 |  |  | 335,177 |  |  | — |  |  | 335,177 |  |  | — |
Annuity investment |  | 12,061 |  |  | 12,061 |  |  | — |  |  | 12,061 |  |  | — |
Interest rate product |  | 24,332 |  |  | 24,332 |  |  | — |  |  | 24,332 |  |  | — |
Accrued interest receivable |  | 41,373 |  |  | 41,373 |  |  | — |  |  | 41,373 |  |  | — |
Liabilities |  |  |  |  |  |  |  |  |  |
Noninterest-bearing deposits |  | 1,433,952 |  |  | 1,433,952 |  |  | — |  |  | 1,433,952 |  |  | — |
Interest-bearing deposits |  | 4,662,967 |  |  | 4,662,967 |  |  | — |  |  | 4,662,967 |  |  | — |
Time deposits |  | 3,036,687 |  |  | 3,050,951 |  |  | — |  |  | 3,050,951 |  |  | — |
Long-term borrowings |  | 76,428 |  |  | 80,329 |  |  | — |  |  | 80,329 |  |  | — |
Interest rate product |  | 23,942 |  |  | 23,942 |  |  | — |  |  | 23,942 |  |  | — |
Accrued interest payable |  | 10,798 |  |  | 10,798 |  |  | — |  |  | 10,798 |  |  | — |

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/820/tableOfContent + Details
Name: | us-gaap_FairValueMeasurementInputsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration